What's breaking now, across thousands of outlets.
Pregnant patients receiving medication to treat opioid use disorder should not reduce their medication dose out of fear that it will worsen withdrawal symptoms in their newborns, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Business leaders in Jalisco are at odds over the impacts of the Guadalajara water crisis on investment, while a new designation of origin seal could boost boost visibility for the state's most iconic…
AbbVie has agreed to a discovery and commercialization deal with Brise Pharma for two preclinical migraine programs. The Beijing-based partner said Monday the agreement actually stemmed from 2024.
INTO, TUI and ASTI direct members not to co-operate with any new model until concerns addressed in letter
FBI investigation into Thomas Markle Sr. faces potential legal complications
Dr. Abdulrahman Al-Sahbi says excessive cosmetic procedures can be corrected, provided the original surgery was done by a qualified specialist.
Africa's latest Ebola outbreak has killed more than 5,300 people, the vast majority of them in the Democratic Republic of Congo, according to the continent's top health agency.
